Tobinick has been issued patents for methods of perispinal administration, of certain recombinant DNA-derived (biologic) therapeutics including the TNF receptor fusion protein etanercept, for the treatment of certain neurologic disorders with widespread unmet medical need, including Alzheimer's disease; pain due to cancer metastasis to bone; severe, intractable, intervertebral disc-related pain and radiculopathy (including sciatica); and myasthenia gravis.
tumor | brain tumor | tumor suppressor gene | Brain tumor | necrosis | Necrosis | Wilms' tumor | Tumor promotion | Tumor necrosis factors | Tumor | Pancoast tumor | gastrointestinal stromal tumor | Bone tumor |